Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability
Zhengjun Gao,
Yiyuan Li,
Fei Wang,
Tao Huang,
Keqi Fan,
Yu Zhang,
Jiangyan Zhong,
Qian Cao,
Tong Chao,
Junling Jia,
Shuo Yang,
Long Zhang,
Yichuan Xiao,
Ji-Yong Zhou,
Xin-Hua Feng and
Jin Jin ()
Additional contact information
Zhengjun Gao: Zhejiang University
Yiyuan Li: Zhejiang University
Fei Wang: Zhejiang University
Tao Huang: Zhejiang University
Keqi Fan: Zhejiang University
Yu Zhang: College of Medicine Zhejiang University
Jiangyan Zhong: Zhejiang University
Qian Cao: College of Medicine Zhejiang University
Tong Chao: Zhejiang University
Junling Jia: Zhejiang University
Shuo Yang: Nanjing Medical University
Long Zhang: Zhejiang University
Yichuan Xiao: Chinese Academy of Sciences/Shanghai Jiao Tong University School of Medicine
Ji-Yong Zhou: Zhejiang University
Xin-Hua Feng: Zhejiang University
Jin Jin: Zhejiang University
Nature Communications, 2017, vol. 8, issue 1, 1-13
Abstract:
Abstract Macrophages, dendritic cells and other innate immune cells are involved in inflammation and host defense against infection. Metabolic shifts in mitochondrial dynamics may be involved in Toll-like receptor agonist-mediated inflammatory responses and immune cell polarization. However, whether the mitochondrial morphology in myeloid immune cells affects anti-tumor immunity is unclear. Here we show that FAM73b, a mitochondrial outer membrane protein, has a pivotal function in Toll-like receptor-regulated mitochondrial morphology switching from fusion to fission. Switching to mitochondrial fission via ablation of Fam73b (also known as Miga2) promotes IL-12 production. In tumor-associated macrophages, this switch results in T-cell activation and enhances anti-tumor immunity. We also show that the mitochondrial morphology affects Parkin expression and its recruitment to mitochondria. Parkin controls the stability of the downstream CHIP–IRF1 axis through proteolysis. Our findings identify mechanisms associated with mitochondrial dynamics that control anti-tumor immune responses and that are potential targets for cancer immunotherapy.
Date: 2017
References: Add references at CitEc
Citations: View citations in EconPapers (1)
Downloads: (external link)
https://www.nature.com/articles/s41467-017-01919-0 Abstract (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-01919-0
Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/
DOI: 10.1038/s41467-017-01919-0
Access Statistics for this article
Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie
More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().